US Patent 10093713 GIP-GLP-1 dual agonist compounds and methods
Patent 10093713 was granted and assigned to Zealand Pharma A/S on October, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10093713 GIP-GLP-1 dual agonist compounds and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
